Kathrine Røe

430 total citations
26 papers, 336 citations indexed

About

Kathrine Røe is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kathrine Røe has authored 26 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Kathrine Røe's work include MRI in cancer diagnosis (10 papers), Radiomics and Machine Learning in Medical Imaging (6 papers) and Prostate Cancer Treatment and Research (5 papers). Kathrine Røe is often cited by papers focused on MRI in cancer diagnosis (10 papers), Radiomics and Machine Learning in Medical Imaging (6 papers) and Prostate Cancer Treatment and Research (5 papers). Kathrine Røe collaborates with scholars based in Norway, United States and Netherlands. Kathrine Røe's co-authors include Therese Seierstad, Dag Rune Olsen, Anne Hansen Ree, Kjersti Flatmark, Sigurd Folkvord, Arne Skretting, Alexandr Kristian, Heidi Lyng, Laure Marignol and Harald Bull Ragnum and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kathrine Røe

26 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathrine Røe Norway 12 138 104 86 77 68 26 336
Zhoulei Li China 11 103 0.7× 62 0.6× 235 2.7× 78 1.0× 57 0.8× 35 573
Ulrike Fasol Germany 8 65 0.5× 121 1.2× 130 1.5× 232 3.0× 46 0.7× 13 467
Zhong-Hua Wang China 6 53 0.4× 116 1.1× 164 1.9× 179 2.3× 170 2.5× 8 413
Mee Kyung Hong South Korea 7 252 1.8× 96 0.9× 74 0.9× 80 1.0× 62 0.9× 7 372
Laurence Morandeau Australia 11 222 1.6× 128 1.2× 47 0.5× 68 0.9× 40 0.6× 28 342
Xi-Chun Hu China 9 47 0.3× 71 0.7× 112 1.3× 112 1.5× 117 1.7× 12 318
Aditya Bansal United States 14 281 2.0× 120 1.2× 113 1.3× 110 1.4× 83 1.2× 29 538
Michio Abe Japan 12 38 0.3× 64 0.6× 150 1.7× 133 1.7× 96 1.4× 40 456
Bi-Yun Wang China 5 41 0.3× 67 0.6× 96 1.1× 73 0.9× 88 1.3× 6 253
Shorouk Dannoon United States 9 165 1.2× 83 0.8× 61 0.7× 71 0.9× 40 0.6× 18 290

Countries citing papers authored by Kathrine Røe

Since Specialization
Citations

This map shows the geographic impact of Kathrine Røe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrine Røe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrine Røe more than expected).

Fields of papers citing papers by Kathrine Røe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrine Røe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrine Røe. The network helps show where Kathrine Røe may publish in the future.

Co-authorship network of co-authors of Kathrine Røe

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrine Røe. A scholar is included among the top collaborators of Kathrine Røe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrine Røe. Kathrine Røe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ree, Anne Hansen, Erta Kalanxhi, Kristina Schee, et al.. (2014). Biomarkers of Histone Deacetylase Inhibitor Activity in a Phase 1 Combined-Modality Study with Radiotherapy. PLoS ONE. 9(2). e89750–e89750. 5 indexed citations
2.
Røe, Kathrine, Åse Bratland, Ljiljana Vlatkovic, et al.. (2013). Hypoxic Tumor Kinase Signaling Mediated by STAT5A in Development of Castration-Resistant Prostate Cancer. PLoS ONE. 8(5). e63723–e63723. 13 indexed citations
3.
Kristian, Alexandr, Line Brennhaug Nilsen, Kathrine Røe, et al.. (2013). Dynamic 18 F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts. Nuclear Medicine and Molecular Imaging. 47(3). 173–180. 7 indexed citations
4.
Ragnum, Harald Bull, Kathrine Røe, Ruth Holm, et al.. (2013). Hypoxia-Independent Downregulation of Hypoxia-Inducible Factor 1 Targets by Androgen Deprivation Therapy in Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 87(4). 753–760. 21 indexed citations
5.
Tahiri, Andliena, Kathrine Røe, Anne Hansen Ree, et al.. (2013). Differential Inhibition of Ex-Vivo Tumor Kinase Activity by Vemurafenib in BRAF(V600E) and BRAF Wild-Type Metastatic Malignant Melanoma. PLoS ONE. 8(8). e72692–e72692. 26 indexed citations
6.
Heyerdahl, Helèn, et al.. (2013). Modifications in Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameters After α-Particle-Emitting 227Th-trastuzumab Therapy of HER2-Expressing Ovarian Cancer Xenografts. International Journal of Radiation Oncology*Biology*Physics. 87(1). 153–159. 9 indexed citations
7.
Røe, Kathrine, Albert J. van der Kogel, Johan Bussink, et al.. (2012). Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer. Radiation Oncology. 7(1). 75–75. 23 indexed citations
8.
Kim, Jong-Ki, et al.. (2012). Superparamagnetic Magnetite Nanoparticles for Cancer Theranostics. 1(4). 271–283. 9 indexed citations
9.
Røe, Kathrine, et al.. (2011). Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts. Radiation Oncology. 6(1). 135–135. 22 indexed citations
11.
Røe, Kathrine, et al.. (2010). Monitoring the Effect of Targeted Therapies in a Gastrointestinal Stromal Tumor Xenograft Using a Clinical PET/CT. Molecular Imaging and Biology. 13(6). 1234–1240. 12 indexed citations
12.
Røe, Kathrine, Alexandr Kristian, Line Brennhaug Nilsen, et al.. (2010). Preclinical dynamic18F-FDG PET – tumor characterization and radiotherapy response assessment by kinetic compartment analysis. Acta Oncologica. 49(7). 914–921. 22 indexed citations
14.
Seierstad, Therese, et al.. (2009). Artificial Neural Networks for Prediction of Response to Chemoradiation in HT29 Xenografts. International Journal of Radiation Oncology*Biology*Physics. 75(2). 506–511. 4 indexed citations
16.
Røe, Kathrine, L.P. Muren, Jarle Rørvik, et al.. (2008). Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. Acta Oncologica. 47(7). 1257–1264. 5 indexed citations
17.
18.
Seierstad, Therese, Kathrine Røe, & Dag Rune Olsen. (2007). Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal tumor model. Radiotherapy and Oncology. 85(2). 187–194. 20 indexed citations
19.
Folkvord, Sigurd, Kjersti Flatmark, Therese Seierstad, et al.. (2007). Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?. Radiotherapy and Oncology. 86(3). 428–434. 19 indexed citations
20.
Røe, Kathrine, et al.. (2002). Developing a Partnership With NAMI and Psychiatric Pharmacists. Schizophrenia Bulletin. 28(3). 525–529. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026